Cargando…

Multipanel assay of 17 tumor‐associated antibodies for serological detection of stage 0/I breast cancer

Because the production of tumor‐associated antibodies (TAA) is a humoral immune response in cancer patients, serum autoantibodies may be detected even in patients with early‐stage tumors. Seventeen recombinant proteins with tags in Escherichia coli (p53, RalA, p90, NY‐ESO‐1, HSP70, c‐myc, galectin‐1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumazaki, Makoto, Ogata, Hideaki, Nabeya, Yoshihiro, Kuwajima, Akiko, Hiwasa, Takaki, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088936/ https://www.ncbi.nlm.nih.gov/pubmed/33605508 http://dx.doi.org/10.1111/cas.14860

Ejemplares similares

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Sistema constructivo prefabricado con lámina y aislamiento térmico multipanel
por: Dommerque Lagunes, Rafael
Publicado: (1995)

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer
por: Ushigome, Mitsunori, et al.
Publicado: (2021)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer
por: Hoshino, Isamu, et al.
Publicado: (2017)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
por: Kobayashi, Sohei, et al.
Publicado: (2016)

A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
por: Shiratori, Fumiaki, et al.
Publicado: (2020)

An ELISA protocol to improve the accuracy and reliability of serological antibody assays
por: Waritani, Takaki, et al.
Publicado: (2017)

Streptococcal toxic-shock syndrome due to Streptococcus dysgalactiaesubspecies equisimilis in breast cancer-related lymphedema: a case report
por: Sumazaki, Makoto, et al.
Publicado: (2017)

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
por: Shimada, Hideaki, et al.
Publicado: (2009)

Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library
por: Kobayashi, Sohei, et al.
Publicado: (2018)

Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions
por: Ogata, Hideaki, et al.
Publicado: (2018)

Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
por: Hu, Liubing, et al.
Publicado: (2022)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
por: Hoshino, Isamu, et al.
Publicado: (2020)

Anti‐FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma
por: Kobayashi, Sohei, et al.
Publicado: (2019)

Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
por: Kobayashi, Sohei, et al.
Publicado: (2021)

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021)

Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays
por: Kweon, Oh Joo, et al.
Publicado: (2020)

Comparison of 17 serological treponemal and nontreponemal assays for syphilis: A retrospective cohort study
por: Sato, Itsuko, et al.
Publicado: (2022)

Comparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodies
por: Li, Weihong, et al.
Publicado: (2017)

Serological assays and host antibody detection in coronavirus-related disease diagnosis
por: Dowlatshahi, Sayeh, et al.
Publicado: (2021)

Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: James, Joe, et al.
Publicado: (2021)

Identification of a novel SEREX antigen family, ECSA, in esophageal squamous cell carcinoma
por: Kagaya, Akiko, et al.
Publicado: (2011)

A serological assay to detect human SARS-CoV-2 antibodies
por: Mahallawi, Waleed H.
Publicado: (2020)

Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Dörschug, Anja, et al.
Publicado: (2021)

Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response
por: Mahmoud, Sally A., et al.
Publicado: (2021)

Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection
por: Bonifacio, Maria Addolorata, et al.
Publicado: (2022)

How to interpret the results of clinical studies: “Multicenter cutting‐edge study” or “real‐world big data study”?
por: Nabeya, Yoshihiro
Publicado: (2023)

Improvement of a recombinant antibody-based serological assay for foot-and-mouth disease virus
por: Muller, Janine D., et al.
Publicado: (2010)

Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2
por: Stocking, Christopher, et al.
Publicado: (2022)

Immunofluorescence Assay for Serologic Diagnosis of SARS
por: Chan, Paul K. S., et al.
Publicado: (2004)

The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n7dg7qlogecvbmhpk8j6k76odm